The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Oscar Braun

Physician

Default user image.

Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr.

Author

  • Daniel Lindholm
  • Robert F Storey
  • Christina Christersson
  • Sigrun Halvorsen
  • Erik L Grove
  • Oscar Braun
  • Christoph Varenhorst
  • Stefan K James

Summary, in English

Ticagrelor treatment has the side effect of increased incidence of dyspnea. Adenosine-induced dyspnea is augmented by ticagrelor and can be alleviated with the adenosine antagonist theophylline. Caffeine is a closely related xanthine derivative.

Department/s

  • Cardiology

Publishing year

2015

Language

English

Pages

465-470

Publication/Series

American Heart Journal

Volume

170

Issue

3

Document type

Journal article

Publisher

Mosby-Elsevier

Topic

  • Cardiac and Cardiovascular Systems

Status

Published

ISBN/ISSN/Other

  • ISSN: 1097-6744